Aleksandra Zdrojowy-Wełna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aleksandra Zdrojowy-Wełna has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Andrzej Szuba
Department of Angiology, Systemic Hypertension and Diabetology. Wrocław Medical University., Borowska 213, 50-556 Wroclaw, Poland
2 shared publicationsKatarzyna Zatońska
Department of Social Medicine, Wroclaw Medical University, Bujwida 44, 50-345 Wrocław, Poland
2 shared publicationsMarek Bolanowski
Department of Endocrinology, Diabetes and Isotope Therapy, Medical University, Wroclaw, Poland
2 shared publications- Aleksandra Jawiarczyk-Przybyłowska
Department and Clinic of Endocrinology and Internal Medicine, Wroclaw Medical University, Wybrzeże Pasteura 4, 50-367 Wroclaw, Poland
1 shared publication - Alessandra Gozzo
Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, 37129 Verona, Italy
1 shared publication - Alessandro Antonelli
Department of Urology, Azienda Ospedaliera Universitaria Integrata of Verona, University of Verona, 37126 Verona, Italy
1 shared publication
Latest Publications
- 3 April 2024
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 25 (3) , 513-539
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
The results of many studies in recent years indicate a significant impact of pituitary function on bone health. The proper function of the pituitary gland has a significant impact on the growth of the skeleton and the appearance of sexual dimorphism. It is also responsible for achieving peak bone mass, which protects against the development of osteoporosis and fractures later in life. It is also liable for the proper remodeling of the skeleton, which is a physiological mechanism managing the proper mechanical resistance of bones and the possibility of its regeneration after injuries. Pituitary diseases causing hypofunction and deficiency of tropic hormones, and thus deficiency of key hormones of effector organs, have a negative impact on the skeleton, resulting in reduced bone mass and susceptibility to pathological fractures. The early appearance of pituitary dysfunction, i.e. in the pre-pubertal period, is responsible for failure to achieve peak bone mass, and thus the risk of developing osteoporosis in later years. This argues for the need for a thorough assessment of patients with hypopituitarism, not only in terms of metabolic disorders, but also in terms of bone disorders. Early and properly performed treatment may prevent patients from developing the bone complications that are so common in this pathology. The aim of this review is to discuss the physiological, pathophysiological, and clinical insights of bone involvement in pituitary disease.
- 3 April 2024
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 25 (3) , 513-539
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
The results of many studies in recent years indicate a significant impact of pituitary function on bone health. The proper function of the pituitary gland has a significant impact on the growth of the skeleton and the appearance of sexual dimorphism. It is also responsible for achieving peak bone mass, which protects against the development of osteoporosis and fractures later in life. It is also liable for the proper remodeling of the skeleton, which is a physiological mechanism managing the proper mechanical resistance of bones and the possibility of its regeneration after injuries. Pituitary diseases causing hypofunction and deficiency of tropic hormones, and thus deficiency of key hormones of effector organs, have a negative impact on the skeleton, resulting in reduced bone mass and susceptibility to pathological fractures. The early appearance of pituitary dysfunction, i.e. in the pre-pubertal period, is responsible for failure to achieve peak bone mass, and thus the risk of developing osteoporosis in later years. This argues for the need for a thorough assessment of patients with hypopituitarism, not only in terms of metabolic disorders, but also in terms of bone disorders. Early and properly performed treatment may prevent patients from developing the bone complications that are so common in this pathology. The aim of this review is to discuss the physiological, pathophysiological, and clinical insights of bone involvement in pituitary disease.
- 30 October 2020
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 71 (5) , 376-381
The FTO gene is not associated with weight gain during six years of observation in the population of the PURE study in Poland
Introduction: We present the first longitudinal study in Poland analysing the association between the fat mass and obesity-associated gene (FTO) polymorphism and changes in anthropometric parameters. Material and methods: 1120 participants of the Prospective Urban Rural (PURE) study in Poland (mean age 53.7) were genotyped for FTO gene polymorphism (rs9939609, rs9930506, rs1421085, rs1121980). Anthropometric parameters were measured at three time points (baseline, after 3 years and after 6 years of observation). Results: The mean body mass index (BMI) in the study group was 28 kg/m2. Overall, there is a significant increase in the mean weight, BMI and waist size over 6 years (p≈0). Although males initially weighed more than females (p=0), over the whole 6 year period women have a greater tendency to increase in weight (p=0.068), BMI (p=0.014) and waist size (p=0.041). Subjects with at least one A allele at rs9939609 initially weigh more on average (77.5 kg vs. 74.7 kg, p=0.027) and have a greater waist size (92 cm vs. 89.5 cm, p=0.025 than those with the TT genotype. The differences in baseline results are more expressed in males than in females. There is no association between the changes in anthropometric parameters over the whole study period of 6 years and the FTO gene. Conclusions: The FTO gene polymorphism is associated with anthropometric parameters in participants from the PURE study in Poland. However, there is no association between the presence of risk alleles and changes of anthropometric parameters over 6 years of observation. Introduction: We present the first longitudinal study in Poland analysing the association between the fat mass and obesity-associated gene (FTO) polymorphism and changes in anthropometric parameters. Material and methods: 1120 participants of the Prospective Urban Rural (PURE) study in Poland (mean age 53.7) were genotyped for FTO gene polymorphism (rs9939609, rs9930506, rs1421085, rs1121980). Anthropometric parameters were measured at three time points (baseline, after 3 years and after 6 years of observation). Results: The mean body mass index (BMI) in the study group was 28 kg/m2. Overall, there is a significant increase in the mean weight, BMI and waist size over 6 years (p≈0). Although males initially weighed more than females (p=0), over the whole 6 year period women have a greater tendency to increase in weight (p=0.068), BMI (p=0.014) and waist size (p=0.041). Subjects with at least one A allele at rs9939609 initially weigh more on average (77.5 kg vs. 74.7 kg, p=0.027) and have a greater waist size (92 cm vs. 89.5 cm, p=0.025 than those with the TT genotype. The differences in baseline results are more expressed in males than in females. There is no association between the changes in anthropometric parameters over the whole study period of 6 years and the FTO gene. Conclusions: The FTO gene polymorphism is associated with anthropometric parameters in participants from the PURE study in Poland. However, there is no association between the presence of risk alleles and changes of anthropometric parameters over 6 years of observation.
- 30 October 2020
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 71 (5) , 376-381
The FTO gene is not associated with weight gain during six years of observation in the population of the PURE study in Poland
Introduction: We present the first longitudinal study in Poland analysing the association between the fat mass and obesity-associated gene (FTO) polymorphism and changes in anthropometric parameters. Material and methods: 1120 participants of the Prospective Urban Rural (PURE) study in Poland (mean age 53.7) were genotyped for FTO gene polymorphism (rs9939609, rs9930506, rs1421085, rs1121980). Anthropometric parameters were measured at three time points (baseline, after 3 years and after 6 years of observation). Results: The mean body mass index (BMI) in the study group was 28 kg/m2. Overall, there is a significant increase in the mean weight, BMI and waist size over 6 years (p≈0). Although males initially weighed more than females (p=0), over the whole 6 year period women have a greater tendency to increase in weight (p=0.068), BMI (p=0.014) and waist size (p=0.041). Subjects with at least one A allele at rs9939609 initially weigh more on average (77.5 kg vs. 74.7 kg, p=0.027) and have a greater waist size (92 cm vs. 89.5 cm, p=0.025 than those with the TT genotype. The differences in baseline results are more expressed in males than in females. There is no association between the changes in anthropometric parameters over the whole study period of 6 years and the FTO gene. Conclusions: The FTO gene polymorphism is associated with anthropometric parameters in participants from the PURE study in Poland. However, there is no association between the presence of risk alleles and changes of anthropometric parameters over 6 years of observation. Introduction: We present the first longitudinal study in Poland analysing the association between the fat mass and obesity-associated gene (FTO) polymorphism and changes in anthropometric parameters. Material and methods: 1120 participants of the Prospective Urban Rural (PURE) study in Poland (mean age 53.7) were genotyped for FTO gene polymorphism (rs9939609, rs9930506, rs1421085, rs1121980). Anthropometric parameters were measured at three time points (baseline, after 3 years and after 6 years of observation). Results: The mean body mass index (BMI) in the study group was 28 kg/m2. Overall, there is a significant increase in the mean weight, BMI and waist size over 6 years (p≈0). Although males initially weighed more than females (p=0), over the whole 6 year period women have a greater tendency to increase in weight (p=0.068), BMI (p=0.014) and waist size (p=0.041). Subjects with at least one A allele at rs9939609 initially weigh more on average (77.5 kg vs. 74.7 kg, p=0.027) and have a greater waist size (92 cm vs. 89.5 cm, p=0.025 than those with the TT genotype. The differences in baseline results are more expressed in males than in females. There is no association between the changes in anthropometric parameters over the whole study period of 6 years and the FTO gene. Conclusions: The FTO gene polymorphism is associated with anthropometric parameters in participants from the PURE study in Poland. However, there is no association between the presence of risk alleles and changes of anthropometric parameters over 6 years of observation.
- Open Access
- 15 October 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3306
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
Background and Purpose: The European Association of Urology guidelines recommend restaging transurethral resection of bladder tumours (reTURB) 2–6 weeks after primary TURB. However, in clinical practice some patients undergo a second TURB procedure after Bacillus Calmette-Guérin immunotherapy (BCG)induction. To date, there are no studies comparing post-BCG reTURB with the classic pre-BCG approach. The aim of this study was to assess whether the performance of reTURB after BCG induction in T1HG bladder cancer is related to potential oncological benefits. Materials and Methods: Data from 645 patients with primary T1HG bladder cancer treated between 2001 and 2019 in 12 tertiary care centres were retrospectively reviewed. The study included patients who underwent reTURB before BCG induction (Pre-BCG group: 397 patients; 61.6%) and those who had reTURB performed after BCG induction (Post-BCG group: 248 patients, 38.4%). The decision to perform reTURB before or after BCG induction was according to the surgeon’s discretion, as well as a consideration of local proceedings and protocols. Due to variation in patients’ characteristics, both propensity-score-matched analysis (PSM) and inverse-probability weighting (IPW) were implemented. Results: The five-year recurrence-free survival (RFS) was 64.7% and 69.1% for the Pre- and Post-BCG groups, respectively, and progression-free survival (PFS) was 82.7% and 83.3% for the Pre- and Post-BCG groups, respectively (both: p > 0.05). Similarly, neither RFS nor PFS differed significantly for a five-year period or in the whole time of observation after the PSM and IPW matching methods were used. Conclusions: Our results suggest that there might be no difference in recurrence-free survival and progression-free survival rates, regardless of whether patients have reTURB performed before or after BCG induction.
- 15 October 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (10) , 3306
Open AccessRestaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
Background and Purpose: The European Association of Urology guidelines recommend restaging transurethral resection of bladder tumours (reTURB) 2–6 weeks after primary TURB. However, in clinical practice some patients undergo a second TURB procedure after Bacillus Calmette-Guérin immunotherapy (BCG)induction. To date, there are no studies comparing post-BCG reTURB with the classic pre-BCG approach. The aim of this study was to assess whether the performance of reTURB after BCG induction in T1HG bladder cancer is related to potential oncological benefits. Materials and Methods: Data from 645 patients with primary T1HG bladder cancer treated between 2001 and 2019 in 12 tertiary care centres were retrospectively reviewed. The study included patients who underwent reTURB before BCG induction (Pre-BCG group: 397 patients; 61.6%) and those who had reTURB performed after BCG induction (Post-BCG group: 248 patients, 38.4%). The decision to perform reTURB before or after BCG induction was according to the surgeon’s discretion, as well as a consideration of local proceedings and protocols. Due to variation in patients’ characteristics, both propensity-score-matched analysis (PSM) and inverse-probability weighting (IPW) were implemented. Results: The five-year recurrence-free survival (RFS) was 64.7% and 69.1% for the Pre- and Post-BCG groups, respectively, and progression-free survival (PFS) was 82.7% and 83.3% for the Pre- and Post-BCG groups, respectively (both: p > 0.05). Similarly, neither RFS nor PFS differed significantly for a five-year period or in the whole time of observation after the PSM and IPW matching methods were used. Conclusions: Our results suggest that there might be no difference in recurrence-free survival and progression-free survival rates, regardless of whether patients have reTURB performed before or after BCG induction.
- Open Access
- 22 January 2020
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 29 (1) , 25-32
The association between FTO gene polymorphism rs9939609 and obesity is sex-specific in the population of PURE study in Poland
Background. Fat mass and obesity-associated gene (FTO) polymorphism remains the strongest known genetic determinant of common obesity. However, its influence depends on ethnicity, and the FTO-mediated predisposition to other metabolic disturbances is questionable. Objectives. The aim of our study was to evaluate the association between FTO rs9939609 polymorphism and metabolic syndrome in a population of Prospective Urban Rural Epidemiology (PURE) study in Poland. Material and methods. We enrolled 1,097 participants of the PURE study (683 women and 414 men) from the Lower Silesian voivodeship. Anthropometrical parameters and blood pressure were measured. Blood samples were taken for an examination of lipid profile and fasting glucose level. Genomic DNA was isolated and FTO polymorphism rs9939609 was genotyped. Results. Male A-allele carriers had significantly higher mean body mass, body mass index (BMI), waist-to-hip ratio (WHR), and waist and hip circumferences than men without risk allele. They were also more often diagnosed with obesity on the basis of BMI and central obesity parameters. No such influence was observed in women. There were no significant associations between FTO polymorphism and metabolic syndrome or its components. Conclusions. Our results suggest a sex-specific association between FTO polymorphism and obesity traits. The occurrence of metabolic syndrome or its components was not related with FTO gene variation in our cohort.
- 22 January 2020
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 29 (1) , 25-32
Open AccessThe association between FTO gene polymorphism rs9939609 and obesity is sex-specific in the population of PURE study in Poland
Background. Fat mass and obesity-associated gene (FTO) polymorphism remains the strongest known genetic determinant of common obesity. However, its influence depends on ethnicity, and the FTO-mediated predisposition to other metabolic disturbances is questionable. Objectives. The aim of our study was to evaluate the association between FTO rs9939609 polymorphism and metabolic syndrome in a population of Prospective Urban Rural Epidemiology (PURE) study in Poland. Material and methods. We enrolled 1,097 participants of the PURE study (683 women and 414 men) from the Lower Silesian voivodeship. Anthropometrical parameters and blood pressure were measured. Blood samples were taken for an examination of lipid profile and fasting glucose level. Genomic DNA was isolated and FTO polymorphism rs9939609 was genotyped. Results. Male A-allele carriers had significantly higher mean body mass, body mass index (BMI), waist-to-hip ratio (WHR), and waist and hip circumferences than men without risk allele. They were also more often diagnosed with obesity on the basis of BMI and central obesity parameters. No such influence was observed in women. There were no significant associations between FTO polymorphism and metabolic syndrome or its components. Conclusions. Our results suggest a sex-specific association between FTO polymorphism and obesity traits. The occurrence of metabolic syndrome or its components was not related with FTO gene variation in our cohort.
- Open Access
- 1 November 2018
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 69 (6) , 644-652
Determinants of obesity in population of PURE study from Lower Silesia
Introduction: The knowledge about obesity pathogenesis is insufficient. The aim of our study was to investigate environmental and individual determinants of obesity in population of PURE study from Lower Silesia. Material and methods: This was a cross sectional observation of 1064 inhabitants of Wroclaw and neighbouring rural area (671 women, 393 men), who took part in PURE study in years 2007-2010. Each participant answered PURE questionnaire and International Physical Activity Questionnaire providing information about obesity risk factors. Anthropometric measurements were collected, blood samples were taken for assessment of FTO gene polymorphism. A stepwise logistic regression analysis was performed to identify the most significant predictors of obesity. Results: 31% of the study group had obesity (BMI over 30 kg/m(2), no difference between men and women), overweight (BMI 25-29.9 kg/m(2)) affected 48.1% of men and 36.7% of women. Determinants of obesity in female group were: rural inhabitancy, chronic medication, unemployment, age, sedentary leisure time activity, non-smoking, hypertension in family, family related stress (p = 0.66 in the Hosmer-Lemeshow test). Determinants of obesity in male group were rural inhabitancy, chronic medication, family related stress, diabetes in family (p = 0.27 in the Hosmer-Lemeshow test). Risk factors for central obesity were similar, however in women oral contraception and physical activity were associated with lower obesity risk. Conclusions: Environmental factors, especially rural inhabitancy and family related stress were associated with higher obesity risk in our study. Employment, smoking, physical activity and use of oral contraception seemed to have protective role in women.
- 1 November 2018
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 69 (6) , 644-652
Open AccessDeterminants of obesity in population of PURE study from Lower Silesia
Introduction: The knowledge about obesity pathogenesis is insufficient. The aim of our study was to investigate environmental and individual determinants of obesity in population of PURE study from Lower Silesia. Material and methods: This was a cross sectional observation of 1064 inhabitants of Wroclaw and neighbouring rural area (671 women, 393 men), who took part in PURE study in years 2007-2010. Each participant answered PURE questionnaire and International Physical Activity Questionnaire providing information about obesity risk factors. Anthropometric measurements were collected, blood samples were taken for assessment of FTO gene polymorphism. A stepwise logistic regression analysis was performed to identify the most significant predictors of obesity. Results: 31% of the study group had obesity (BMI over 30 kg/m(2), no difference between men and women), overweight (BMI 25-29.9 kg/m(2)) affected 48.1% of men and 36.7% of women. Determinants of obesity in female group were: rural inhabitancy, chronic medication, unemployment, age, sedentary leisure time activity, non-smoking, hypertension in family, family related stress (p = 0.66 in the Hosmer-Lemeshow test). Determinants of obesity in male group were rural inhabitancy, chronic medication, family related stress, diabetes in family (p = 0.27 in the Hosmer-Lemeshow test). Risk factors for central obesity were similar, however in women oral contraception and physical activity were associated with lower obesity risk. Conclusions: Environmental factors, especially rural inhabitancy and family related stress were associated with higher obesity risk in our study. Employment, smoking, physical activity and use of oral contraception seemed to have protective role in women.